Pegasus Crowned Health Consultancy of the Year at 2014 Sabre Emea Awards
June 4, 2014 |
Brighton consultancy adds top honour to its award wins
Last night Pegasus, the UK’s leading independent health communications consultancy, was crowned EMEA Health Consultancy of the Year 2014 at the prestigious SABRE Award ceremony in London.
This high-profile award recognises excellence in health communications across Europe, the Middle East and Africa and superior achievement in branding, reputation and engagement. Selected as winner not only by peers in the health industry but also by leaders in the FMCG, corporate and financial sectors, the Brighton-based consultancy successfully beat stiff competition from Red Door, Virgo and First Light.
Paul Holmes, founder and CEO of The Holmes Report and judge of the SABRE EMEA Awards said of Pegasus; “Healthcare PR firms are being forced to look for new avenues of growth, and those looking to the consumer health space have found at least a couple of established competitors taking the lead. Pegasus, based on the south coast of England and focused on ‘inspiring healthy decisions’, is probably the best of them, a firm with an outstanding workplace culture and an impressive creative track record. The expansion of the firm’s digital and social media capabilities was another key factor in its success.”
Managing Director Lisa Bradley said; “This is an incredible achievement for us. We’re all delighted, not only because this acknowledges our established international capability but also because it recognises how we have evolved and expanded our services in what has been a challenging time for all in the health industry. We continue to deliver campaigns that span local, national and international markets; have created a network of global affiliate agencies across five continents; and now provide clients with a fully integrated communications offer through our digital, social and corporate services – all key to our thriving and successful business.”
Pegasus also won an In2 Innovation SABRE Award for its ‘Slimewatch’ campaign on behalf of Bayer UK in partnership with Markettiers 4DC and the EMEA Sponsorship Gold SABRE Award for its work with Novo Nordisk on Team Novo Nordisk.
ENDS
For more information please contact Maria Boiling or Lesley Fitzpatrick-Feurstein at Pegasus on 01273 712000 or mboiling@thisispegasus.co.uk /lfitzpatrick-feurstein@thisispegasus.co.uk
Notes to editors
Located in Brighton with a 70-strong team of communications experts, Pegasus specialises in helping the public and private sector communicate healthy messages through integrated communications programmes. Focusing on an overall mission to ‘Inspire Healthy Decisions’ and driven by a health first, sector second approach, Pegasus has a demonstrative track record of creating and implementing campaigns that inspire change. The Pegasus approach to planning starts by investing time understanding the varied nature of decisions in every area of people’s day to day lives, from the general public through to the healthcare professionals that treat and the policy makers that shape the environment in which they work. The consultancy’s fully integrated approach blends unrivalled health contacts across the international, national, consumer, regional and specialist press, with in-house corporate, creative, social and digital services. Pegasus’s clients currently include GSK, Pfizer, Boehringer Ingelheim, Bayer, Thornton & Ross, Holland & Barrett, Sanofi, Bio-Oil, Danone, Homedics, Novo Nordisk and Pierre Fabre. For more information please visit www.thisispegasus.co.uk.
This content was provided by Inizio
Company Details
Latest Content from Inizio
How will AI change field training?
Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...
Inizio Ignite Sparks a New Era of Connected Advisory Solutions
Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.
MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke
The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
How DataGateway unified oncology data for real-world insights & market intelligence
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
Preparing for ASH 2025: Pharma’s role in hematology innovation
As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...
AI without limits: A smarter, integrated approach to Medical Affairs
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...